Stock listing

OTC:IVRN Innoveren Scientific Inc. Stock

Follow Innoveren Scientific Inc. into a list and get an email when it puts out news.

Share price · OTC:IVRN

$0.0003 USD 0.0000 (0.0%)

Close on Oct 14, 2026 · Data provided by Twelve Data

Innoveren Scientific Inc. logo
Ticker
OTC:IVRN
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

Innoveren Scientific Divests Device & Receives Capital Infusion

Oct 3, 2023

H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC

Dec 29, 2022

H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 Days

Sep 19, 2022

H-CYTE Completes Acquisition of Jantibody

Sep 8, 2022

H-CYTE to Expect the Completed Acquisition of Jantibody Within 30 Days

Jul 22, 2022

H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise

Mar 4, 2022

H-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc.

Jan 11, 2022

Issued by another party

H-CYTE Names Michael Yurkowsky Chief Executive Officer

Dec 6, 2021

H-CYTE Combines Clinical Outcomes and Scientific Development to Launch New Centers for Respiratory Health

Sep 8, 2021

H-CYTE Announces Publication of Additional Data that Further Supports Efficacy of Innovative PRP-PBMC Treatment Aimed at Helping to Improve Overall Lung Health

Jul 6, 2021

All Innoveren Scientific Inc. news

Decks

Innoveren Scientific Inc. on 6ix

News releases
40 in all · newest Oct 3, 2023 · oldest 2017
Decks
7 decks · latest Dec 21, 2023

Log in to ask 6ix AI your own questions about Innoveren Scientific Inc.